Robert K McClure

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment
    Robert K McClure
    University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, NC 27510 7160, USA
    Psychiatry Res 148:121-32. 2006
  2. ncbi request reprint Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment
    Robert K McClure
    University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina 27510 7160, United States
    Schizophr Res 98:29-39. 2008
  3. pmc Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type
    Robert K McClure
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599, USA
    Psychiatry Res 211:1-10. 2013
  4. pmc Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors
    Martin Styner
    Department of Computer Science, University of North Carolina, Chapel Hill, NC 27599 3175, USA
    Proc Natl Acad Sci U S A 102:4872-7. 2005
  5. ncbi request reprint Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?
    Daniel R Weinberger
    Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, 10 Center Dr, Bldg 10, Room 3C 101, MSC 1255, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 59:553-8. 2002
  6. ncbi request reprint Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series
    Stefano Marenco
    Intramural Research Program, Clinical Brain Disorders Branch, National Institute of Mental Health, Building 10, Room 4S235, Bethesda, MD 20892, USA
    Schizophr Res 57:221-6. 2002

Detail Information

Publications6

  1. ncbi request reprint Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment
    Robert K McClure
    University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, NC 27510 7160, USA
    Psychiatry Res 148:121-32. 2006
    ..Longitudinal regional brain volume change in schizophrenia patients is likely physiologic and therefore potentially reversible...
  2. ncbi request reprint Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment
    Robert K McClure
    University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina 27510 7160, United States
    Schizophr Res 98:29-39. 2008
    ..Although the results do not directly show that brief periods of atypical antipsychotic treatment are associated with basal ganglia and cortical volume change, there is much evidence to suggest that such an association exists...
  3. pmc Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type
    Robert K McClure
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599, USA
    Psychiatry Res 211:1-10. 2013
    ..Treatment-related related longitudinal shape change was not observed within the studied timeframe. Our results provide additional evidence for disrupted cortico-basal ganglia-thalamo-cortical circuits in schizophrenia...
  4. pmc Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors
    Martin Styner
    Department of Computer Science, University of North Carolina, Chapel Hill, NC 27599 3175, USA
    Proc Natl Acad Sci U S A 102:4872-7. 2005
    ..Our results suggest that genetics have a stronger influence on the shape of lateral ventricles than do the disease-related changes in schizophrenia...
  5. ncbi request reprint Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?
    Daniel R Weinberger
    Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, 10 Center Dr, Bldg 10, Room 3C 101, MSC 1255, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 59:553-8. 2002
  6. ncbi request reprint Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series
    Stefano Marenco
    Intramural Research Program, Clinical Brain Disorders Branch, National Institute of Mental Health, Building 10, Room 4S235, Bethesda, MD 20892, USA
    Schizophr Res 57:221-6. 2002
    ..No clear improvement in psychosis or in cognition was observed over the course of the study. CX516 at the doses tested did not appear to yield dramatic effects as a sole agent, but inference from this study is limited...